홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate → 8-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane

HRID 928580
인쇄

반응식

HRID 928580 반응식
[CH:1]12[N:8]([C:9]3[C:10]4[C:32]([C:33]5[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=5)=[CH:31][S:30][C:11]=4[N:12]=[C:13]([O:15][CH:16]4[CH2:21][CH:20]5[CH2:22][CH:17]4[CH2:18][N:19]5C(OC(C)(C)C)=O)[N:14]=3)[CH:5]([CH2:6][CH2:7]1)[CH2:4][O:3][CH2:2]2>C(Cl)Cl.FC(F)(F)C(O)=O>[CH:20]12[CH2:22][CH:17]([CH:16]([O:15][C:13]3[N:14]=[C:9]([N:8]4[CH:1]5[CH2:7][CH2:6][CH:5]4[CH2:4][O:3][CH2:2]5)[C:10]4[C:32]([C:33]5[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=5)=[CH:31][S:30][C:11]=4[N:12]=3)[CH2:21]1)[CH2:18][NH:19]2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 1

HCID 89579513Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate

생성물 1

HCID 895799438-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane수율 2.7%

시약·촉매·용매 2

HCID 6344Dichloromethane용매HCID 6422Trifluoroacetic acid용매

실험 절차

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate (269 mg, 0.503 mmol) was dissolved in DCM (2 mL) and trifluoroacetic acid (2 mL). The mixture was stirred at room temperature for 2 hrs and then evaporated. The residue was dissolved in water (2 mL) and DCM (2 mL). Solid sodium bicarbonate was added to neutralize the remaining acid. The layers were separated and the aqueous was extracted with DCM (2×2 mL). The combined organic layers were evaporated to give a brown solid. This was purified by preparative HPLC (acidic method 1). Fractions containing the target compound (by LCMS) were combined and evaporated. The residue was dissolved in methanol and applied to an SCX cartridge (2 g, equilibrated with methanol). The cartridge was washed with methanol (2 column volumes) then 0.5 M ammonia in methanol (2 column volumes). The ammonia solution was evaporated to give 8-[2-(2-azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane as a white solid (6 mg). LCMS RT=3.16 min. M+1=435.

후처리

  1. customevaporated
  2. dissolutionThe residue was dissolved in water (2 mL)
  3. additionSolid sodium bicarbonate was added
  4. customThe layers were separated
  5. extractionthe aqueous was extracted with DCM (2×2 mL)
  6. customThe combined organic layers were evaporated
  7. customto give a brown solid
  8. customThis was purified by preparative HPLC (acidic method 1)
  9. additionFractions containing the target compound (by LCMS)
  10. customevaporated
  11. dissolutionThe residue was dissolved in methanol
  12. washThe cartridge was washed with methanol (2 column volumes)
  13. customThe ammonia solution was evaporated

출처 및 근거

ORD 기록
ord-074e5b7f4d51400fb0cccd52cd3efb82
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09290511B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트